|
AU2015205934A1
|
|
Methods of analysis of polymorphisms and uses thereof
|
|
US2013281319A1
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
AU2012203045A1
|
|
Methods Of Analysis Of Polymorphisms And Uses Thereof
|
|
EP2443258A1
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
US2011184044A1
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
WO2008075977A2
|
|
Methods and compositions for the assessment of cardiovascular function and disorders
|
|
EP2074224A2
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
CA2653671A1
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
US2009287508A1
|
|
Methods of analysis of polymorphisms and uses thereof
|
|
CN101356287A
|
|
Methods and compositions for the assessment of cardiovascular function and disorders
|
|
EP1951902A1
|
|
Methods and compositions for the assessment of cardiovascular function and disorders
|
|
WO2006123954A1
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
CN101180409A
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
CN101180408A
|
|
Methods for the assessment of risk of developing lung cancer using analysis of genetic polymorphisms
|
|
MX2007014220A
|
|
Methods and compositions for assessment of pulmonary function and disorders.
|
|
AU2006244683A1
|
|
Methods and compositions for assessment of pulmonary function and disorders
|
|
CN101218357A
|
|
Method for examining pulmonary function and abnormality and composition therefor
|
|
AU2006248189A1
|
|
Methods of analysis of polymorphisms and uses thereof
|
|
JP2006314315A
|
|
Method for examining pulmonary function and abnormality and composition therefor
|
